Mark B Geyer

30PUBLICATIONS
133CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Child and adolescent developmentHaematologyMedical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jun 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Jun 18, 2026
Outcomes of adolescents and young adults with AML treated on pediatric vs adult protocols.

|Dec 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis.

Joseph M Rocco, Joseph H Oved, Rikita J Patel

|Dec 06, 2025
Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure.

Kuo-Kai Chin, Brian J Ball, Yasmin Abaza

|Aug 27, 2025
CD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia.

Mark B Geyer, Susan DeWolf, Xiaoli Mi

|Jan 15, 2025
Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype.

Pallavi Galera, Deepika Dilip, Andriy Derkach

Pageof 5

Frequent Collaborators

7 joint publications

Andriy Derkach

6 joint publications

Wenbin Xiao

5 joint publications

Ahmet Dogan

4 joint publications

Jacob L Glass